Email this article 
Biomarkers in Prediction of Preeclampsia
Abstract
Preeclampsia is being pregnant-specific, and notably contributes to maternal, and perinatal morbidity and mortality worldwide. An effective predictive test for preeclampsia could facilitate early diagnosis, focused surveillance and well timed delivery; however, restrained alternatives presently exist. A first-trimester screening algorithms has been evolved and demonstrated to expect preterm preeclampsia, with poor utility for term disease, wherein the greatest burden lies. Biomarkers consisting of sFlt-1 and placental growth factor also are now getting used clinically in cases of suspected preterm preeclampsia; their high negative predictive value allows assured exclusion of disease in women with normal results, however sensitivity is modest. There has been a concerted attempt to become aware of ability novel biomarkers that could enhance prediction. These in large part originate from organs concerned in preeclampsia’s pathogenesis, which includes placental, cardiovascular and urinary biomarkers. This review outlines the clinical imperative for an effective test and those already in use and summarises modern-day preeclampsia biomarker studies.
Keywords
Full Text:
PDFReferences
- Ness, Roberta B., and James M. Roberts. "Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications." American journal of obstetrics and gynecology 175.5 (1996): 1365-1370.
- Von Dadelszen, Peter, Laura A. Magee, and James M. Roberts. "Subclassification of preeclampsia." Hypertension in pregnancy 22.2 (2003): 143-148.
- Brosens, Ivo, et al. "The “Great Obstetrical Syndromes” are associated with disorders of deep placentation." American journal of obstetrics and gynecology 204.3 (2011): 193-201.
- Chaiworapongsa, Tinnakorn, et al. "Pre-eclampsia part 1: current understanding of its pathophysiology." Nature Reviews Nephrology 10.8 (2014): 466-480.
- Jung, Eunjung, et al. "The etiology of preeclampsia." American Journal of Obstetrics and Gynecology 226.2 (2022): S844-S866.
- Myatt, Leslie, and James M. Roberts. "Preeclampsia: syndrome or disease?" Current hypertension reports 17.11 (2015): 1-8.
- Burton, G. J., et al. "Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy." Placenta 30.6 (2009): 473-482.
- Moldenhauer, Julie S., et al. "The frequency and severity of placental findings in women with preeclampsia are gestational age dependent." American journal of obstetrics and gynecology 189.4 (2003): 1173-1177.
- Ogge, Giovanna, et al. "Placental lesions associated with maternal under perfusion are more frequent in early-onset than in late-onset preeclampsia." Journal of perinatal medicine 39.6 (2011): 641-652.
- Matthiesen, Leif, et al. "Immunology of preeclampsia." Immunology of Pregnancy 89 (2005): 49-61.
- Maynard, Sharon E., et al. "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia." The Journal of clinical investigation 111.5 (2003): 649-658.
- Venkatesha, Shivalingappa, et al. "Soluble endoglin contributes to the pathogenesis of preeclampsia." Nature medicine 12.6 (2006): 642-649.
- Cindrova-Davies, Tereza, et al. "Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling." Cardiovascular research 89.3 (2011): 671-679.
- Kumar, Ashok, et al. "IL-10, TNF-α & IFN-γ: potential early biomarkers for preeclampsia." Cellular immunology 283.1-2 (2013): 70-74.
- Roberts, James M., et al. "Preeclampsia: an endothelial cell disorder." American journal of obstetrics and gynecology 161.5 (1989): 1200-1204.
- Hahn, Sinuhe, et al. "Neutrophil NETs in reproduction: from infertility to preeclampsia and the possibility of fetal loss." Frontiers in immunology 3 (2012): 362.
- Umapathy, Anandita, Lawrence W. Chamley, and Joanna L. James. "Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies." Angiogenesis 23.2 (2020): 105-117.
- Fosheim, Ingrid Knutsdotter, et al. "Decidua basalis and acute atherosis: Expression of atherosclerotic foam cell associated proteins." Placenta 107 (2021): 1-7.
- Allerkamp, Hanna H., et al. "Something old, something new: Digital quantification of uterine vascular remodelling and trophoblast plugging in historical collections provides new insight into adaptation of the utero-placental circulation." Human Reproduction 36.3 (2021): 571-586.
- Blois, Sandra M., et al. "A potential pathophysiological role for galectins and the renin–angiotensin system in preeclampsia." Cellular and molecular life sciences 72.1 (2015): 39-50.
- Verlohren, S., et al. "Uterine artery Doppler, birth weight and timing of onset of pre‐eclampsia: providing insights into the dual etiology of late‐onset pre‐eclampsia." Ultrasound in Obstetrics & Gynecology 44.3 (2014): 293-298.
- Soto, Eleazar, et al. "Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal under perfusion." The Journal of Maternal-Fetal & Neonatal Medicine 25.5 (2012): 498-507.
- Vatten, Lars J., et al. "Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia." American journal of obstetrics and gynecology 196.3 (2007): 239-e1.
- Crispi, F., et al. "Predictive value of angiogenic factors and uterine artery Doppler for early‐versus late‐onset pre‐eclampsia and intrauterine growth restriction." Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology31.3 (2008): 303-309.
- Romero, Roberto, et al. "A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate." The journal of maternal-fetal & neonatal medicine 21.1 (2008): 9-23.
- Redman, C. W., I. L. Sargent, and A. C. Staff. "IFPA Senior Award Lecture: making sense of pre-eclampsia–two placental causes of preeclampsia?" Placenta 35 (2014): S20-S25.
- Hahn, Sinuhe, Olav Lapaire, and Nandor Gabor Than. "Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?" Expert Review of Molecular Diagnostics 15.5 (2015): 617-629.
- Robillard, Pierre-Yves, et al. "Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia." American Journal of Obstetrics and Gynecology 226.2 (2022): S867-S875.
- Hürter, Hanna, et al. "Prevention of pre-eclampsia after infertility treatment: preconceptional minimalisation of risk factors." Best Practice & Research Clinical Endocrinology & Metabolism 33.1 (2019): 127-132.
- Than, Nándor Gábor, et al. "Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies." Placenta (2022).
- Scioscia, Marco, et al. "Endothelial dysfunction and metabolic syndrome in preeclampsia: an alternative viewpoint." Journal of reproductive immunology 108 (2015): 42-47.
- Stark, Michael J., et al. "Alterations in the maternal peripheral microvascular response in pregnancies complicated by preeclampsia and the impact of fetal sex." Journal of the Society for Gynecologic Investigation 13.8 (2006): 573-578.
- Dijk, Marie van, and Cees Oudejans. "(Epi) genetics of pregnancy-associated diseases." Frontiers in genetics 4 (2013): 180.
- Johnson, Matthew P., et al. "Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene." PloS one 7.3 (2012): e33666.
- Lau, Sien Yee, et al. "Tumor necrosis factor‐alpha, interleukin‐6, and interleukin‐10 levels are altered in preeclampsia: a systematic review and meta‐analysis." American journal of reproductive immunology 70.5 (2013): 412-427.
- Dunk, Caroline E., et al. "Functional evaluation of STOX1 (STORKHEAD-BOX PROTEIN 1) in placentation, preeclampsia, and preterm birth." Hypertension 77.2 (2021): 475-490.
- Miralles, Francisco, et al. "Long-term cardiovascular disorders in the STOX1 mouse model of preeclampsia." Scientific reports 9.1 (2019): 1-13.
- Yong, Hannah EJ, et al. "Genetic approaches in preeclampsia." Preeclampsia (2018): 53-72.
- Burton, Graham J., et al. "Pre-eclampsia: pathophysiology and clinical implications." Bmj 366 (2019).
- Hahn, Sinuhe, et al. "Feto-maternal microchimerism: the pre-eclampsia conundrum." Frontiers in Immunology 10 (2019): 659.
- Jiménez, Karen Marcela, et al. "Identifying new potential genetic biomarkers for HELLP syndrome using massive parallel sequencing." Pregnancy Hypertension 22 (2020): 181-190.
- Poon, Liona C., et al. "A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia: Compiled by the Pregnancy and Non‐Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)." International Journal of Gynaecology and Obstetrics154.Suppl 1 (2021): 3.
- Loscalzo, Joseph, and Albert‐Laszlo Barabasi. "Systems biology and the future of medicine." Wiley Interdisciplinary Reviews: Systems Biology and Medicine 3.6 (2011): 619-627.
- Robinson, Scott W., Marco Fernandes, and Holger Husi. "Current advances in systems and integrative biology." Computational and structural biotechnology journal 11.18 (2014): 35-46.
- Tarca, Adi L., Roberto Romero, and Sorin Draghici. "Analysis of microarray experiments of gene expression profiling." American journal of obstetrics and gynecology 195.2 (2006): 373-388.
- Yong, Hannah EJ, et al. "Significance of the placental barrier in antenatal viral infections." Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867.12 (2021): 166244.
- Menkhorst, Ellen, et al. "Galectin-7 impairs placentation and causes preeclampsia features in mice." Hypertension 76.4 (2020): 1185-1194.
- Founds, Sandra A., et al. "Altered global gene expression in first trimester placentas of women destined to develop preeclampsia." Placenta 30.1 (2009): 15-24.
- Li, Hui, et al. "Single cell transcriptome research in human placenta." Reproduction 160.6 (2020): R155-R167.
- Pavličev, Mihaela, et al. "Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface." Genome research 27.3 (2017): 349-361.
- Várkonyi, T1, et al. "Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar." Placenta 32 (2011): S21-S29.
- Nishizawa, H., et al. "Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia." Placenta 28.5-6 (2007): 487-497.
- Enquobahrie, Daniel A., et al. "Differential placental gene expression in preeclampsia." American journal of obstetrics and gynecology 199.5 (2008): 566-e1.
- Sitras, V., et al. "Differential placental gene expression in severe preeclampsia." Placenta 30.5 (2009): 424-433.
- Winn, Virginia D., et al. "Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2." Endocrinology 150.1 (2009): 452-462.
- Than, Nandor Gabor, et al. "Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia." Frontiers in immunology 9 (2018): 1661.
- Knöfler, Martin, and Jürgen Pollheimer. "Human placental trophoblast invasion and differentiation: a particular focus on Wnt signaling." Frontiers in genetics 4 (2013): 190.
- E. Davies, Jessica, et al. "Epithelial-mesenchymal transition during extravillous trophoblast differentiation." Cell adhesion & migration 10.3 (2016): 310-321.
- Hansson, Stefan R., Åsa Nääv, and Lena Erlandsson. "Oxidative stress in preeclampsia and the role of free fetal hemoglobin." Frontiers in physiology (2015): 516.
- Szilagyi, Andras, et al. "Placenta-specific genes, their regulation during villous trophoblast differentiation and dysregulation in preterm preeclampsia." International journal of molecular sciences 21.2 (2020): 628.
- Leavey, Katherine, Shannon A. Bainbridge, and Brian J. Cox. "Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia." PloS one 10.2 (2015): e0116508.
- Leavey, Katherine, et al. "Unsupervised placental gene expression profiling identifies clinically relevant subclasses of human preeclampsia." Hypertension 68.1 (2016): 137-147.
- Yuen, R. K. C., and W. P. Robinson. "A high capacity of the human placenta for genetic and epigenetic variation: Implications for assessing pregnancy outcome." Placenta 32 (2011): S136-S141.
- Coorens, Tim HH, et al. "Inherent mosaicism and extensive mutation of human placentas." Nature 592.7852 (2021): 80-85.
- Benton, Samantha J., et al. "The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology." American journal of obstetrics and gynecology 219.6 (2018): 604-e1.
- Leavey, Katherine, David Grynspan, and Brian J. Cox. "Both “canonical” and “immunological” preeclampsia subtypes demonstrate changes in placental immune cell composition." Placenta 83 (2019): 53-56.
- Gibbs, Isaac, et al. "Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia." American Journal of Obstetrics and Gynecology 220.1 (2019): 110-e1.
- Michela, Battistelli. "Liquid biopsy: a family of possible diagnostic tools." Diagnostics 11.8 (2021): 1391.
- Crowley, Emily, et al. "Liquid biopsy: monitoring cancer-genetics in the blood." Nature reviews Clinical oncology 10.8 (2013): 472-484.
- Than, Gábor N., Hans Bohn, and Dénes G. Szabó. Advances in pregnancy-related protein research functional and clinical applications. CRC Press, 2020.
- Cole, Laurence A. "hCG, the wonder of today's science." Reproductive Biology and Endocrinology 10.1 (2012): 1-18.
- Than, Nándor Gábor, et al. "Placental protein 13 (PP13)–a placental immunoregulatory galectin protecting pregnancy." Frontiers in immunology5 (2014): 348.
- LO YM, CorbettaN, et al. "Presence of fetal DNA in maternal plasma and serum." Lancet 350.9076 (1997): 485-487.
- Than, Nándor Gábor, et al. "Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies." Placenta (2022).
- Poon, Leo LM, et al. "Presence of fetal RNA in maternal plasma." Clinical chemistry 46.11 (2000): 1832-1834.
- Chiu, Rossa WK, et al. "Time profile of appearance and disappearance of circulating placenta-derived mRNA in maternal plasma." Clinical chemistry52.2 (2006): 313-316.
- Whitehead, Clare L., Susan P. Walker, and Stephen Tong. "Measuring circulating placental RNAs to non‐invasively assess the placental transcriptome and to predict pregnancy complications." Prenatal diagnosis36.11 (2016): 997-1008.
- Nagy, Bálint, Zoltán Csanádi, and Róbert Póka. "The importance of" free" nucleic acids in the non-invasive diagnostics." Orvosi Hetilap 157.48 (2016): 1900-1909.
- Nair, Soumyalekshmi, and Carlos Salomon. "Extracellular vesicles as critical mediators of maternal-fetal communication during pregnancy and their potential role in maternal metabolism." Placenta 98 (2020): 60-68.
- Salomon, Carlos, et al. "Placental exosomes as early biomarker of preeclampsia: potential role of exosomal microRNAs across gestation." The Journal of Clinical Endocrinology & Metabolism 102.9 (2017): 3182-3194.
- Kandzija, Neva, et al. "Placental extracellular vesicles express active dipeptidyl peptidase IV; levels are increased in gestational diabetes mellitus." Journal of extracellular vesicles 8.1 (2019): 1617000.
- McElrath, Thomas F., et al. "Late first trimester circulating microparticle proteins predict the risk of preeclampsia< 35 weeks and suggest phenotypic differences among affected cases." Scientific reports 10.1 (2020): 1-15.
- Than, N. G., et al. "Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studies." Placenta (2022).
- Rasmussen, Morten, et al. "RNA profiles reveal signatures of future health and disease in pregnancy." Nature 601.7893 (2022): 422-427.
- Farina, Antonio, et al. "Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks." American journal of obstetrics and gynecology 203.6 (2010): 575-e1.
- Purwosunu, Yuditiya, et al. "Prediction of preeclampsia by analysis of cell-free messenger RNA in maternal plasma." American journal of obstetrics and gynecology 200.4 (2009): 386-e1.
- Lv, Yan, et al. "Roles of microRNAs in preeclampsia." Journal of cellular physiology 234.2 (2019): 1052-1061.
- Srinivasan, Srimeenakshi, et al. "Discovery and verification of extracellular miRNA biomarkers for non-invasive prediction of pre-eclampsia in asymptomatic women." Cell Reports Medicine 1.2 (2020): 100013.
- Chaiworapongsa, Tinnakorn, et al. "Differences and similarities in the transcriptional profile of peripheral whole blood in early and late-onset preeclampsia: insights into the molecular basis of the phenotype of preeclampsiaa." Journal of perinatal medicine 41.5 (2013): 485-504.
- Tarca, Adi L., et al. "Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study." The Journal of Maternal-Fetal & Neonatal Medicine 34.21 (2021): 3463-3474.
- Tsang, Jason CH, et al. "Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics." Proceedings of the National Academy of Sciences 114.37 (2017): E7786-E7795.
- Gomez-Lopez, Nardhy, et al. "The cellular transcriptome in the maternal circulation during normal pregnancy: a longitudinal study." Frontiers in immunology 10 (2019): 2863.
- Ngo, Thuy TM, et al. "Noninvasive blood tests for fetal development predict gestational age and preterm delivery." Science 360.6393 (2018): 1133-1136.
- Jauniaux, Eric, et al. "Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure." The American journal of pathology 157.6 (2000): 2111-2122.
- Moffett, Ashley, and Charlie Loke. "Immunology of placentation in eutherian mammals." Nature Reviews Immunology 6.8 (2006): 584-594.
- Saito, Shigeru. "Th17 cells and regulatory T cells: new light on pathophysiology of preeclampsia." Immunology and cell biology 88.6 (2010): 615.
- Saito, Shigeru, and Masatoshi Sakai. "Th1/Th2 balance in preeclampsia." Journal of reproductive immunology 59.2 (2003): 161-173.
- Tarca, Adi L., et al. "The prediction of early preeclampsia: Results from a longitudinal proteomics study." PloS one 14.6 (2019): e0217273.
- Erez, Offer, et al. "The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study." PloS one 12.7 (2017): e0181468.
-Wilkerson, Matthew D., and D. Neil Hayes. "ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking." Bioinformatics 26.12 (2010): 1572-1573.
-Roberge, Stéphanie, et al. "Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis." Fetal diagnosis and therapy 31.3 (2012): 141-146.
-Legro, Richard S. "Periconception care of the infertile patient: Are we doing enough? “Fertility and Sterility 118.4 (2022): 653-655.
-Romero, Roberto, et al. "Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity." American journal of obstetrics and gynecology 217.3 (2017): 282-302.
-de Alwis, Natasha, et al. "Novel approaches to combat preeclampsia: from new drugs to innovative delivery." Placenta 102 (2020): 10-16.
-Morales-Prieto, Diana M., Rodolfo R. Favaro, and Udo R. Markert. "Placental miRNAs in feto-maternal communication mediated by extracellular vesicles." Placenta 102 (2020): 27-33.
-McLaughlin, Kelsey, et al. "Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction." American Journal of Obstetrics and Gynecology226.2 (2022): S1145-S1156.
DOI: http://dx.doi.org/10.52155/ijpsat.v34.2.4671
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Maged Naser
This work is licensed under a Creative Commons Attribution 4.0 International License.